2021-01-06,"Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazias Paxalisib and Kintaras VAL-083 in GBM AGILE Trial"
2020-12-17,"CEO, MD & Executive Director James Garner Just Bought 10% More Shares In Kazia Therapeutics Limited (ASX:KZA)"
2020-12-11,Analysts Just Made A Massive Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts
2020-12-10,Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG
2020-12-09,Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG
2020-12-09,Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals
2020-12-08,Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals
2020-12-03,"Kazia Therapeutics (KZIA): Phase IIa Shows Good Safety, Consistent Efficacy"
2020-11-30,KTRA: VAL-083 Poster Updates
2020-11-26,Should You Take Comfort From Insider Transactions At Kazia Therapeutics Limited (ASX:KZA)?
2020-11-19,"The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway"
2020-11-18,"The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted"
2020-11-17,"Kazia Presents Further Paxalisib Data At Sno, Confirming Earlier Positive Safety And Efficacy Signals In Glioblastoma"
2020-11-17,"Kazia Presents Further Paxalisib Data At Sno, Confirming Earlier Positive Safety And Efficacy Signals In Glioblastoma"
2020-10-16,Kazia Executes Agreement To Commence GBM Agile Pivotal Study
2020-10-15,Kazia Executes Agreement To Commence GBM Agile Pivotal Study
2020-09-22,Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
2020-09-21,Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
2020-09-02,Edison issues ADR outlook on Kazia Therapeutics (KZIA)
2020-09-01,We're Hopeful That Kazia Therapeutics (ASX:KZA) Will Use Its Cash Wisely
2020-08-23,"US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For Malignant Glioma, Including DIPG"
2020-08-23,"US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For Malignant Glioma, Including DIPG"
2020-08-20,US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma
2020-08-19,US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma
2020-08-07,US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG
2020-08-06,US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG
2020-06-22,"Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs"
2020-06-22,"Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs"
2020-06-01,Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
2020-05-31,Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
2020-05-29,Iain Ross Is The Independent Chairman of the Board of Kazia Therapeutics Limited (ASX:KZA) And They Just Picked Up 19% More Shares
2020-05-25,Did You Manage To Avoid Kazia Therapeutics' (ASX:KZA) Devastating 86% Share Price Drop?
2020-04-07,Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
2020-02-24,Is Kazia Therapeutics Limited's (ASX:KZA) CEO Paid At A Competitive Rate?
2020-01-13,Edison issues ADR update on Kazia Therapeutics (KZIA)
2019-12-11,"Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma"
2019-12-10,"Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma"
2019-12-02,Edison issues ADR outlook on Kazia Therapeutics (KZIA)
2019-11-28,If You Had Bought Kazia Therapeutics (ASX:KZA) Shares A Year Ago You'd Have Made 60%
2019-11-25,Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
2019-11-24,Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
2019-10-27,Kazia Raises A$4.0 Million to Progress R&D Programs
2019-09-13,Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer
2019-09-12,St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
2019-07-22,Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center
2019-07-21,Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center
2019-07-17,Kazia calls for greater awareness of the deadliest brain cancer in the US
2019-06-03,How Kazia Therapeutics Limited (ASX:KZA) Can Impact Your Portfolio Volatility
2019-05-20,Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
2019-05-19,Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
2019-05-08,New positive data from phase IIa trial in brain cancer patients
2019-05-08,Kazia calls for greater awareness of the deadliest gynecological cancer in the US
2019-05-07,Kazia calls for greater awareness of the most lethal women's disease in Australia
2019-04-19,Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?
2019-04-01,Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
2019-04-01,Edison issues ADR update on Kazia Therapeutics (KZIA)
2019-03-31,Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
2019-03-25,Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting
2019-03-25,Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting
2019-01-23,Why Kazia Therapeutics Limiteds (ASX:KZA) CEO Pay Matters To You
2018-11-19,"Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million"
2018-10-29,Edison issues ADR update on Kazia Therapeutics (KZIA)
2018-10-29,Progress Update on GDC-0084 Program
2018-10-22,Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer
2018-10-17,Kazia Raises A$3.4 Million to Progress R&D Programs
2018-10-10,Cantrixil Phase I Study Progresses To Next Stage
2018-10-10,Cantrixil Phase I Study Progresses To Next Stage
2018-10-01,John Theurer Cancer Center Enrolls First Two Patients Nationwide for Groundbreaking Phase II Clinical Trial for Glioblastoma
2018-06-19,Kazia Releases Preliminary Cantrixil Phase I Data
2018-05-11,Edison Issues ADR Outlook on Kazia Therapeutics (KZIA)
2018-03-28,Commencement Of Phase II Clinical Study Of GDC-0084
2018-03-28,Commencement Of Phase II Clinical Study Of GDC-0084
2018-02-23,Kazia Receives FDA Orphan Designation for GDC-0084
2018-02-23,Kazia Receives FDA Orphan Designation for GDC-0084
